Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation [0.03%]
CYP3A5基因型对肾移植患者他克莫司的起始剂量及血药浓度监测的影响
Nikhil Rao,Taylor Carcella,Neha Patel et al.
Nikhil Rao et al.
Objectives: LCP tac has a recommended starting dose of 0.14 mg/kg/day in kidney transplant. The goal of this study was to assess the influence of CYP3A5 on perioperative LCP tac dosing and monitoring. ...
Observational Study
Pharmacogenetics and genomics. 2023 Apr 1;33(3):59-65. DOI:10.1097/FPC.0000000000000494 2023
Association of the ACE and AGT gene polymorphisms with global disparities in COVID-19-related deaths [0.03%]
ACE和AGT基因多态性与全球COVID-19相关死亡差异的关联分析
Yolande B Saab,Zahi S Nakad,Stephanie J Mehanna
Yolande B Saab
Objective: The aim of the study was to investigate the gene polymorphisms of angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin type 1 receptor (AT1R) in association with coronavirus disease 2019 ...
Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapy [0.03%]
SLC22A1基因多态性rs628031(G/A)对新诊断的印度2型糖尿病患者二甲双胍单药治疗疗效的影响研究
Shalini Singh,Ashwin Kumar Shukla,Kauser Usman et al.
Shalini Singh et al.
Objectives: Type 2 diabetes (T2D) imposes an enormous burden all over the world in both developed and developing countries. Inter-individual differences are attributed to polymorphisms in candidate genes resulting in alte...
A lifetime economic research of universal HLA-B*58:01 genotyping or febuxostat initiation therapy in Chinese gout patients with mild to moderate chronic kidney disease [0.03%]
HLA-B*58:01基因分型或Febuxostat起始治疗在中国轻中度慢性肾脏病痛风患者中的经济学评价
Yuan Hong,Xichuang Chen,Zhiping Li et al.
Yuan Hong et al.
Objective: To evaluate Chinese long-term economic impact of universal human leukocyte antigen B (HLA-B)*58:01 genotyping-guided urate-lowering therapy or febuxostat initiation therapy for gout patients with mild to modera...
Thomas Chen,Peter H ODonnell,Merisa Middlestadt et al.
Thomas Chen et al.
Pharmacogenomics is a crucial piece of personalized medicine. Preemptive pharmacogenomic testing is only used sparsely in the inpatient setting and there are few models to date for fostering the adoption of pharmacogenomic treatment in the ...
Pregnane X receptor gene variant rs7643645 and total mortality in subjects with nonalcoholic fatty liver disease [0.03%]
孕烯醇酮X受体基因变异rs7643645与非酒精性脂肪肝疾病患者的总体死亡率
Aki J Käräjämäki,Janne Hukkanen,Olavi Ukkola
Aki J Käräjämäki
Pregnane X receptor (PXR) gene variants rs7643645 and rs2461823 are reported to associate with clinically and histologically more severe liver injury in nonalcoholic fatty liver disease (NAFLD). It is known that the more progressive the NAF...
MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway [0.03%]
微小核糖核酸-139-3p通过靶向KIF18B和失活Wnt/β-连环蛋白通路抑制膀胱尿路上皮癌的恶性进展
Wenbin Zhang,Zhihua Liu
Wenbin Zhang
Objective: Bladder cancer is a highly prevalent disease worldwide. We aimed to investigate the effect of miRNA/mRNA signaling on bladder urothelial carcinoma (BUC). ...
Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects [0.03%]
有机阴离子转运多肽、P-糖蛋白和乳腺癌耐药蛋白对观察到的三苯氧胺和内分泌影响浓度及副作用的影响
Denise N Keller,Samantha J Medwid,Cameron D Ross et al.
Denise N Keller et al.
Objective: Drug transporters are important determinants of drug disposition and response. Tamoxifen is an antiestrogen for breast cancer therapy known for adverse drug reactions (ADRs). In this study, the involvement of O...
Marco Calabró,Silvana Briuglia,Concetta Crisafulli et al.
Marco Calabró et al.
Background: There is evidence suggesting a link between weight-related disorders and bipolar disorder (BD). The pathophysiology of the association includes psychological, social and psychotropic treatment-related variable...
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice [0.03%]
ABCB1、CYP3A5和CYP3A4基因多态性对房颤患者达比加群凝血酶时间及稳态浓度影响的临床研究
Dmitry Alekseevitch Sychev,Aleksey Vladimirovich Sokolov,Olga Vilorovna Reshetko et al.
Dmitry Alekseevitch Sychev et al.
Objective: The study of ABCB1 and CYP3A4/3A5 gene polymorphism genes is promising in terms of their influence on prothrombin time variability, the residual equilibrium concentration of direct oral anticoagulants (DOACs) i...